NASACORT

This brand name is authorized in Brazil, Canada, Germany, Estonia, Spain, Finland, France, Ireland, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug NASACORT contains one active pharmaceutical ingredient (API):

1 Triamcinolone UNII F446C597KA - TRIAMCINOLONE ACETONIDE

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. Read about Triamcinolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NASACORT Nasal Spray suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AD11	Triamcinolone	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720090089117
Country: CA	Health Products and Food Branch	Identifier(s): 02213834, 02417510
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00900525, 04439767, 08442192, 10811981
Country: EE	Ravimiamet	Identifier(s): 1667752, 1667785
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61970
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 029494, 034900, 090662
Country: FR	Base de données publique des médicaments	Identifier(s): 69649126
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 152496, 24756, 381542
Country: IE	Health Products Regulatory Authority	Identifier(s): 34201, 34217, 34278
Country: MT	Medicines Authority	Identifier(s): MA1470/00801, MA1470/00901
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 287M97
Country: NL	Z-Index G-Standaard	Identifier(s): 14215330
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50857
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100329642
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68039001, W68039002
Country: SG	Health Sciences Authority	Identifier(s): 10821P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7073011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683060700015
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/21.5.1/0715